Cargando…
Universal Ready-to-Use Immunotherapeutic Approach for the Treatment of Cancer: Expanded and Activated Polyclonal γδ Memory T Cells
In the last years, important progresses have been registered in the treatment of patients suffering from oncological/haematological malignancies, but more still needs to be done to reduce toxicity and side effects, improve outcome and offer new strategies for relapsed or refractory disease. A remark...
Autores principales: | Polito, Vinicia A., Cristantielli, Rosaria, Weber, Gerrit, Del Bufalo, Francesca, Belardinilli, Tamascia, Arnone, Claudia M., Petretto, Andrea, Antonucci, Laura, Giorda, Ezio, Tumino, Nicola, Pitisci, Angela, De Angelis, Biagio, Quintarelli, Concetta, Locatelli, Franco, Caruana, Ignazio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883509/ https://www.ncbi.nlm.nih.gov/pubmed/31824502 http://dx.doi.org/10.3389/fimmu.2019.02717 |
Ejemplares similares
-
Choice of costimulatory domains and of cytokines determines CAR T-cell activity in neuroblastoma
por: Quintarelli, Concetta, et al.
Publicado: (2018) -
Identification of New Soluble Factors Correlated With the Development of Graft Failure After Haploidentical Hematopoietic Stem Cell Transplantation
por: Weber, Gerrit, et al.
Publicado: (2021) -
Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas
por: Arnone, Claudia Manuela, et al.
Publicado: (2021) -
Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma
por: Tumino, Nicola, et al.
Publicado: (2021) -
Manipulating the Metabolism to Improve the Efficacy of CAR T-Cell Immunotherapy
por: Pellegrino, Marsha, et al.
Publicado: (2020)